Focus Taiwan
Date: 2018/12/29
By: Chang Ming-hsuan and Frances Huang 

Taipei, Dec. 29 (CNA) A biotech company has recalled its high blood pressure drug after finding that several batches of the medication contained a potentially cancer-causing substance, Taiwan’s Food and Drug Administration (FDA) said Saturday.

Chiayi-headquartered Siu Guan Chemical Industrial Co. began on Thursday to recall its 50 mg Cosar F.C. Tablets after they were found to contain N-Nitrosodiethylamine (NDEA), a substance suspected of causing cancer, but the move was first made public Saturday.

The recall, which will continue until Jan. 27, 2019, involves 3 million tablets produced over 11 batches, the FDA said.

The incident is the latest of several cases of potentially tainted high blood pressure medication available in Taiwan and around the world.    [FULL  STORY]